MXPA03007212A - Particulas de liberacion modulada para suministro en aerosol. - Google Patents

Particulas de liberacion modulada para suministro en aerosol.

Info

Publication number
MXPA03007212A
MXPA03007212A MXPA03007212A MXPA03007212A MXPA03007212A MX PA03007212 A MXPA03007212 A MX PA03007212A MX PA03007212 A MXPA03007212 A MX PA03007212A MX PA03007212 A MXPA03007212 A MX PA03007212A MX PA03007212 A MXPA03007212 A MX PA03007212A
Authority
MX
Mexico
Prior art keywords
aerosol delivery
release particles
modulated release
modulated
particles
Prior art date
Application number
MXPA03007212A
Other languages
English (en)
Spanish (es)
Inventor
L Adjei Akwete
Original Assignee
Aeropharm Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeropharm Technology Inc filed Critical Aeropharm Technology Inc
Publication of MXPA03007212A publication Critical patent/MXPA03007212A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03007212A 2001-02-15 2002-02-06 Particulas de liberacion modulada para suministro en aerosol. MXPA03007212A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/784,659 US6596262B2 (en) 2001-02-15 2001-02-15 Modulated release particles for aerosol delivery
PCT/US2002/004235 WO2002066010A1 (en) 2001-02-15 2002-02-06 Modulated release particles for aerosol delivery

Publications (1)

Publication Number Publication Date
MXPA03007212A true MXPA03007212A (es) 2003-12-04

Family

ID=25133132

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007212A MXPA03007212A (es) 2001-02-15 2002-02-06 Particulas de liberacion modulada para suministro en aerosol.

Country Status (7)

Country Link
US (1) US6596262B2 (de)
EP (1) EP1361859A4 (de)
JP (1) JP2004522768A (de)
AU (1) AU2002251928B2 (de)
CA (1) CA2438213C (de)
MX (1) MXPA03007212A (de)
WO (1) WO2002066010A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
IL158771A0 (en) * 2001-06-22 2004-05-12 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug
KR20050044523A (ko) * 2001-11-19 2005-05-12 벡톤 디킨슨 앤드 컴퍼니 입자 형태의 약제학적 조성물
EP1498116A1 (de) * 2002-03-20 2005-01-19 Hosokawa Micron Corporation Verfahren zur herstellung chemikalien enthaltender kompositteilchen
US7683029B2 (en) * 2003-05-07 2010-03-23 Philip Morris Usa Inc. Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
US6827969B1 (en) 2003-12-12 2004-12-07 General Electric Company Field repairable high temperature smooth wear coating
KR20070104563A (ko) 2004-12-20 2007-10-26 오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 생물학적 존재의 제어된 방출
CN101141974A (zh) * 2005-02-09 2008-03-12 明治乳业株式会社 蛋白质导入用载体、使用了该载体的蛋白质导入剂、蛋白质导入方法和蛋白质导入细胞及其制造方法
JP2006249072A (ja) * 2005-02-09 2006-09-21 Osaka Univ タンパク質導入用担体、前記担体を用いたタンパク質導入剤、タンパク質導入方法、およびタンパク質導入細胞ならびにその製造方法
US20080182786A1 (en) * 2005-02-09 2008-07-31 Meiji Dairies Corporation Support For Protein Transfer, Protein Transfer Agent Using the Support, Protein Transfer Method, Cell Having Protein Transferred Thereinto and Method of Producing the Same
GB0504657D0 (en) * 2005-03-05 2005-04-13 Psimedica Ltd Compositions and methods of treatment
US7638477B2 (en) * 2005-03-09 2009-12-29 Alberto-Culver Company Sustained-release fragrance delivery system
US20060257355A1 (en) * 2005-05-10 2006-11-16 Abiomed, Inc. Impregnated polymer compositions and devices using them
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008149192A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2182987A4 (de) * 2007-07-30 2011-11-02 Medacure International Inc Formulierung für immunsystemmodulator
WO2009073216A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
PT105270B (pt) 2010-08-26 2012-05-31 Domino Ind Ceramicas S A Camada de sílica com libertação lenta de fragrância, telha cerâmica e respectivo processo de produção
US9078878B2 (en) 2010-12-01 2015-07-14 Alderbio Holdings Llc Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
JP6190723B2 (ja) 2010-12-01 2017-08-30 アルダーバイオ ホールディングス エルエルシー 抗ngf組成物およびその使用
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US9067988B2 (en) 2010-12-01 2015-06-30 Alderbio Holdings Llc Methods of preventing or treating pain using anti-NGF antibodies
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
US9539324B2 (en) 2010-12-01 2017-01-10 Alderbio Holdings, Llc Methods of preventing inflammation and treating pain using anti-NGF compositions
US11285107B2 (en) * 2017-05-04 2022-03-29 Nanologica Ab Process for manufacturing porous silica particles loaded with at least one bioactive compound adapted for lung, nasal, sublingual, and/or pharyngeal delivery
CN114306283B (zh) * 2022-01-05 2023-03-21 南方医科大学 一种复合微粒及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB611567A (en) * 1945-12-29 1948-11-01 Niles Bement Pond Co Tracer controlled duplicating machine
BE565793A (de) * 1957-03-19 1900-01-01
GB1429184A (en) 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
IE46865B1 (en) 1977-04-29 1983-10-19 Allen & Hanburys Ltd Device for dispensing medicaments
BR8007911A (pt) 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
CH646429A5 (de) 1980-03-27 1984-11-30 Ciba Geigy Ag 4-halogen-oxetan-2-one und verfahren zu deren herstellung.
US4963367A (en) 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
EP0273700B1 (de) * 1986-12-25 1992-03-04 Sumitomo Electric Industries Limited Verfahren zur Herstellung eines medizinischen Vinylchloridharzmaterials
US5002048A (en) 1989-12-12 1991-03-26 Makiej Jr Walter J Inhalation device utilizing two or more aerosol containers
US5169433A (en) 1990-07-18 1992-12-08 Formulogics, Inc. Method of preparing mixtures of active ingredients and excipients using liquid carbon dioxide
DE69332240T2 (de) * 1992-06-12 2003-04-10 Teijin Ltd., Osaka Ultrafeines pulver zur inhalation und dessen herstellung
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
US5571531A (en) * 1994-05-18 1996-11-05 Mcmaster University Microparticle delivery system with a functionalized silicone bonded to the matrix
CN1228708A (zh) * 1996-09-04 1999-09-15 有限会社多特 经口给药用含肽药物组合物
US5843881A (en) * 1997-02-13 1998-12-01 The Procter & Gamble Company Spray compositions
GB9808802D0 (en) * 1998-04-24 1998-06-24 Glaxo Group Ltd Pharmaceutical formulations
EP1104287B9 (de) * 1998-08-13 2012-12-19 Sol-Gel Technologies Ltd. Verfahren zur herstellung von mit funktionalisierten molekülen beladene oxid-mikrokapseln und die daraus erhaltenen produkte

Also Published As

Publication number Publication date
EP1361859A4 (de) 2009-05-20
EP1361859A1 (de) 2003-11-19
CA2438213A1 (en) 2002-08-29
US6596262B2 (en) 2003-07-22
WO2002066010A1 (en) 2002-08-29
AU2002251928B2 (en) 2005-04-28
US20020119117A1 (en) 2002-08-29
CA2438213C (en) 2008-04-22
JP2004522768A (ja) 2004-07-29

Similar Documents

Publication Publication Date Title
MXPA03007214A (es) Particulas de liberacion modulada para suministro en aerosol.
MXPA03007256A (es) Particulas de liberacion modulada para sumunistro en aerosol.
MXPA03007257A (es) Particulas de liberacion modulada para suministro en aerosol.
MXPA03007212A (es) Particulas de liberacion modulada para suministro en aerosol.
MXPA03007213A (es) Particulas de liberacion modulada para suministro en aerosol.
HK1068431A1 (en) Improved media delivery platform
AU2002244133A1 (en) Delivery systems for mycotechnologies, mycofiltration and mycoremediation
MX261045B (es) Sistemas de suministro de agentes beneficos.
WO2003090724A8 (fr) Particules enrobees a liberation prolongee et comprimes les contenant
AU2001273629A1 (en) Modulated release particles for lung delivery
AUPR602401A0 (en) Sustained release delivery system
AU2001280481A1 (en) A particle perfume delivery system
AU148104S (en) Plug-in aerosol dispenser
MXPA03007253A (es) Particulas de liberacion modulada para suministro en aerosol.
MXPA03006233A (es) Valvula surtidora de aerosol.
HK1050610A1 (en) Microemulsion aerosol composition.
AU2002222145A1 (en) Particulate inhalation carrier
AU2001275992A1 (en) Date specific package delivery system
AUPR395001A0 (en) Secure transport container
AU2001281288A1 (en) Modulated release therapeutic aerosols
EP1406765A4 (de) Tröpfchenabgabesystem
GB0100115D0 (en) Delivery systems
AU2002314376A1 (en) Heatable container having aroma releasing means
AU2002338412A1 (en) Controlled release particles
AU2002217308A1 (en) System for delivering goods

Legal Events

Date Code Title Description
GB Transfer or rights
FG Grant or registration